Group One Trading’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Group One Trading’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-27,735	Closed	-$498K	–	5697
2017 Q4	$498K	Buy	+27,735	New	+$341K	﹤0.01%	2261
2017 Q1	–	Sell	-3,216	Closed	-$37.3K	–	5289
2016 Q4	$44K	Buy	+3,216	New	+$44.9K	﹤0.01%	3337
2016 Q1	–	Sell	-675	Closed	-$8.53K	–	5290
2015 Q4	$12K	Buy	+675	New	+$12.1K	﹤0.01%	4134
2015 Q3	–	Sell	-1,027	Closed	-$23.5K	–	5482
2015 Q2	$17K	Buy	+1,027	New	+$17.8K	﹤0.01%	4120
2014 Q1	–	Sell	-2,137	Closed	-$18.3K	–	5823
2013 Q4	$20K	Buy	2,137 +400	+23%	+$2.85K	﹤0.01%	4250
2013 Q3	$11K	Buy	+1,737	New	+$10.8K	﹤0.01%	4467

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Group One Trading's SCMP Position: Q1 2018 in Review

Group One Trading sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 27,735 shares — an estimated $498K sold.

Group One Trading first reported a position in SCMP in Q3 2013 and held it in 6 quarters. The position peaked at $498K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Group One Trading reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Group One Trading sold 27,735 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $498K.
Group One Trading first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2013 and held it in 6 quarters.
Group One Trading's Sucampo Pharmaceuticals, Inc. position peaked at $498K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Group One Trading's 13F filing for Q1 2018, filed 11 May 2018.